IL-18BP Antibodies

Santa Cruz Biotechnology features a diverse variety of IL-18BP monoclonal antibodies for research focused on understanding IL-18 binding protein. IL-18BP monoclonal antibodies are validated for multiple applications, including western blotting (WB), immunoprecipitation (IP), immunofluorescence (IF), immunohistochemistry with paraffin-embedded sections (IHCP), flow cytometry (FCM), and enzyme-linked immunosorbent assay (ELISA). IL-18 binding protein functions as a crucial regulator of the immune response by acting as a natural antagonist to IL-18, a pro-inflammatory cytokine. Through binding to IL-18, IL-18BP modulates its activity, thereby influencing the production of interferon-gamma and other inflammatory mediators. Understanding IL-18BP function is essential for elucidating its role in various diseases, including autoimmune disorders and cancer. IL-18BP research has revealed significant implications in inflammatory conditions and potential therapeutic strategies. Investigating IL-18BP expression patterns helps researchers understand its distribution across different tissues and cell types. Current studies focus on how IL-18BP influences various signaling cascades and cellular responses. Santa Cruz Biotechnology monoclonal antibodies enable researchers to advance their understanding of immune regulation and explore new therapeutic possibilities in IL-18 signaling pathways.